Registration Dossier

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
From 9 January to 13 February 1979
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Limited study summary, no GLP

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1979
Report Date:
1979

Materials and methods

Test guideline
Qualifier:
equivalent or similar to
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Principles of method if other than guideline:
This study used Swiss albinomice. In the range finding study, mice (10 males and 10 females) were administered 500, 1000, 2500, 5000 and 7500 mg/kg of test substance by oral gavage. In the main study, 30 male and 30 female mice, received 1500, 2000, 2500, 3000, 3500 and 4000 mg/kg of test substance. All the animals were closely observed until day 14 post-dosing for signs of acute intoxication and mortality.
GLP compliance:
not specified
Test type:
standard acute method
Limit test:
no

Test material

Reference
Name:
Unnamed
Type:
Constituent
Details on test material:
Batch No.: 52829055Purity: not specified

Test animals

Species:
mouse
Strain:
other: Swiss albino
Sex:
male/female
Details on test animals and environmental conditions:
TEST ANIMALS- Source: Bio Breeding Laboratories of Canada Ltd., Ottawa, Canada- Age at study initiation: Approximately 30 days old- Weight at study initiation: 18-22 grams- Fasting period before study: 14-16 hours- Housing: shoebox bins- Diet (e.g. ad libitum): a pelleted diet (Purina Mouse Chow)- Water (e.g. ad libitum): ad libitum- Acclimation period: 2 weeksENVIRONMENTAL CONDITIONS- Temperature (°F): 70-75 ℉- Humidity (%): 40-50%- Air changes (per hr): - Photoperiod (hrs dark / hrs light): 12 hours daylight and 12 hours darkness

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
other: Tween-80
Details on oral exposure:
VEHICLE- Concentration in vehicle: 1.5%- Amount of vehicle (if gavage): 20 mL/kg- Justification for choice of vehicle: Due to its relative innocuous nature and ability to provide a stable homogeneous suspension.- Lot/batch no. (if required): - Purity: MAXIMUM DOSE VOLUME APPLIED:
Doses:
Range finding study: 500, 1000, 2500, 5000, 7500 mg/kgMain study: 1500, 2000, 2500, 3000, 3500, 4000 mg/kg
No. of animals per sex per dose:
Range finding study: 2 males and 2 females per doseMain study: 5 males and 5 females per dose
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days - Frequency of observations and weighing: twice daily- Necropsy of survivors performed: yes- Other examinations performed: clinical signs, body weight and histopathology
Statistics:
From the accumulated mortality data the LD50 value and its 95% confidence limits were calculated according to the method of Litchfield and Wilcoxon, Journal of Pharmacology and Experimental Therapeutics, Vol. 96, 99-113, 1949.

Results and discussion

Preliminary study:
Within 24 hours and 14 days after administration, there was 100% mortality in the 2500 and 7500 mg/kg dose groups, and 50% mortality within the 5000 mg/kg dose group. No mortality was observed in the 500 mg/kg and 1000 mg/kg dose groups within 24 hours and 14 days. Animals surviving the 14-day observation period showed increased body weights. In no animal gross lesions were observed at necropsy.
Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
2 250 mg/kg bw
Based on:
act. ingr.
95% CL:
1 875 - 2 700
Mortality:
24-hour mortality was 0, 30%, 70%, 50%, 80% and 100% for the respective dose groups. 14-day mortality was 0, 50%, 70%, 60%, 90% and 100% for the respective dose groups.
Clinical signs:
Signs of acute intoxication were absent in animals receiving 1500 mg/kg; however, in animals receiving 2000 mg/kg or greater, signs of acute intoxication consisted of decreased muscle tone, decreased activity and alertness as well as tonic convulsions and cyanosis with marked absence of the postural reflex. In animals receiving 2500 mg/kg there was a marked absence of the righting reflex. Among those animals receiving 3000 mg/kg there was an absence of the pinnal reflex.
Body weight:
An increase of body weight was noted during the observation period in the 1500-3000 mg/kg dose group.
Gross pathology:
All animals in both the range finding and definitive study were subjected to gross necropsy at the termination of the respenctive observation times. There was no lesions observed at necropsy in animals that had received 1500 mg/kg of the test substance; however, in animals that had received 2000 mg/kg or greater, there was evidence of gastric hemorrhage as demonstrated by the presence of coagulated blood in the stomach.

Applicant's summary and conclusion

Interpretation of results:
not classified
Remarks:
Migrated informationCriteria used for interpretation of results: EU
Conclusions:
The test substance produced signs of acute intoxication at doses greater than 2000 mg/kg.
Executive summary:

This study used Swiss albino in the range finding study, mice ( 2/sex/dose) were administered 500, 1000, 2500, 5000 and 7500 mg/kg of test substance by oral gavage. In the main study mice (5/sex/dose) were exposed to 1500, 2000, 2500, 3000, 3500 and 4000 mg/kg of test substance. All the animals were closely observed until day 14 post-dosing for signs of acute intoxication and mortality.

The test substance produced signs of acute intoxication at doses greater than 2000 mg/kg. The LD50 was set at 2250 mg/kg bw